Cardiol Therapeutics (CRDL.TO) Buy, Sell or…

Home

Daily Stock Opinions and Ratings

Cardiol Therapeutics (CRDL.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

1.46

-0.04 (2.67%)

as of Jun 12, 2026, 8:00:00 pm Market Open.

35 watching

BUY

COVID-19 heart issues? The company makes a synthetic CBD. Their original work saw CBD helped to reduce inflammation of the heart. It is expected they will start to re-purpose their product for COVID patients. This would help accelerate testing by about 2 years. This could lead to product being sold in Canada very quickly. A great opportunity.

COMMENT

They struck a deal with Noramco, to sell into Canada and Mexico, synthetic CPD (for heart medication). They have enough cash to self finance the heart research.

HOLD

He has met management twice and they had their IPO in mid-December. They have looked into the use of CBD to use as an anti-inflammatory for heart patients. They are working on developing synthetic CBD. They think they could produce 1 millions grams of CBD this year. This creates a great opportunity and they have enough technology to advance their strategy. If they can sell the CBC, the company is fairly valued.

Showing 1 to 3 of 3 entries

Cardiol Therapeutics (CRDL.TO) Frequently Asked Questions

What is Cardiol Therapeutics stock symbol?

Cardiol Therapeutics is a Canadian stock, trading under the symbol CRDL.TO (previously CRDL-T on Stockchase) on the Toronto Stock Exchange (CRDL-CT). It is usually referred to as TSX:CRDL or CRDL.TO

Is Cardiol Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on CRDL.TO (previously CRDL-T on Stockchase) on Stockchase. Read the latest expert commentary for Cardiol Therapeutics.

Is Cardiol Therapeutics a good investment or a top pick?

Cardiol Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cardiol Therapeutics.

Why is Cardiol Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Cardiol Therapeutics.

Is Cardiol Therapeutics worth watching?

Cardiol Therapeutics is followed by 35 investors on Stockchase and is a trending stock that is worth watching.

What is Cardiol Therapeutics stock price?

On 2026-06-12, Cardiol Therapeutics (CRDL.TO) stock closed at a price of $1.46.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Cardiol Therapeutics (CRDL.TO)